The histone deacetylase inhibitor PCI-24781 as a putative radiosensitizer in pediatric glioblastoma cell lines
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2867
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The histone deacetylase inhibitor PCI-24781 as a putative radiosensitizer in pediatric glioblastoma cell lines ; volume:16 ; number:1 ; day:18 ; month:4 ; year:2016 ; pages:1-11 ; date:12.2016
Cancer cell international ; 16, Heft 1 (18.4.2016), 1-11, 12.2016
- Urheber
-
Andrade, Pamela Viani de
- Beteiligte Personen und Organisationen
-
Andrade, Augusto Faria
Queiroz, Rosane Gomes de Paula
Scrideli, Carlos Alberto
Tone, Luiz Gonzaga
Valera, Elvis Terci
SpringerLink (Online service)
- DOI
-
10.1186/s12935-016-0306-5
- URN
-
urn:nbn:de:1111-20160420821
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Andrade, Pamela Viani de
- Andrade, Augusto Faria
- Queiroz, Rosane Gomes de Paula
- Scrideli, Carlos Alberto
- Tone, Luiz Gonzaga
- Valera, Elvis Terci
- SpringerLink (Online service)
Ähnliche Objekte (12)
Senzitization of glioblastoma to TRAIL-induced apoptosis by histone deacetylase inhibitors
Enhanced efficacy of histone deacetylase inhibitor combined with bromodomain inhibitor in glioblastoma
Histone deacetylase 6 in cancer
Histone deacetylase inhibitors reverse resistance to methylating agents : mechanisms in malignant melanoma and glioblastoma cells
Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus
Regulatory mechanisms of histone deacetylase 2 Sumoylation
Role of histone deacetylase 11 in neuroblastoma
Dendritic cell development requires histone deacetylase activity
Limited proteolysis of human histone deacetylase 1
Development of class IIa histone deacetylase inhibitors
Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
Histone deacetylase inhibitors: clinical implications for hematological malignancies
Senzitization of glioblastoma to TRAIL-induced apoptosis by histone deacetylase inhibitors
Enhanced efficacy of histone deacetylase inhibitor combined with bromodomain inhibitor in glioblastoma
Histone deacetylase 6 in cancer
Histone deacetylase inhibitors reverse resistance to methylating agents : mechanisms in malignant melanoma and glioblastoma cells
Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus
Regulatory mechanisms of histone deacetylase 2 Sumoylation
Role of histone deacetylase 11 in neuroblastoma
Dendritic cell development requires histone deacetylase activity
Limited proteolysis of human histone deacetylase 1
Development of class IIa histone deacetylase inhibitors
Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
Histone deacetylase inhibitors: clinical implications for hematological malignancies
Senzitization of glioblastoma to TRAIL-induced apoptosis by histone deacetylase inhibitors
Enhanced efficacy of histone deacetylase inhibitor combined with bromodomain inhibitor in glioblastoma
Histone deacetylase 6 in cancer
Histone deacetylase inhibitors reverse resistance to methylating agents : mechanisms in malignant melanoma and glioblastoma cells
Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus
Regulatory mechanisms of histone deacetylase 2 Sumoylation
Role of histone deacetylase 11 in neuroblastoma
Dendritic cell development requires histone deacetylase activity
Limited proteolysis of human histone deacetylase 1
Development of class IIa histone deacetylase inhibitors
Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro